Lauren B. Bruckner, M.D., Ph.D.

MAJOR MEDICAL PRACTICE
Pediatric Hematology, Oncology, and Hematopoietic Stem Cell Transplantation
Subspecialty interests:
*Pediatric Hematopoietic Stem Cell Transplantation (HSCT)
*Infections of the Immunocompromised Host

MAJOR CLINICAL RESPONSIBILITIES
Attending Physician in the Division of Pediatric Hematology/Oncology (PHO)
• Assume primary responsibility for a cohort of hematology, oncology, and HSCT patients
• Attending physician on the inpatient service 5 weeks/year
• PHO outpatient clinic 1-2 half days per week

Professional Background

Dr. Bruckner is Associate Professor of Pediatrics and Oncology, and the Clinical Director of the Pediatric General Inpatient Units at the Golisano Children's Hospital, University of Rochester Medical Center (URMC). She earned her medical degree and PhD in Microbiology and Immunology at SUNY at Upstate Medical Center. Subsequently, she completed her residency in Pediatrics and fellowship training in hematology and oncology at URMC.

Associate Professor of Pediatrics & Oncology, Dr. Bruckner leads and provides oversight to the clinical operations of the Golisano Children's Hospital including the admission process and bed capacity management, optimizing the use of the electronic medical record (eRecord), patient and family satisfaction, and quality of care, safety, and regulatory initiatives. Dr. Bruckner holds multiple leadership positions including:

Medical Director of Patient Engagement
Attending Physician in the Division of Pediatric Hematology/Oncology (PHO)
Executive Leadership Committee, Golisano Children's Hospital
Clinical Council, Strong Memorial Hospital
Clinical Council, Golisano Children's Hospital
Quality and Safety Council, Golisano Children's Hospital
Clinical Architect for eRecord, University of Rochester Medical Center
Lead Clinical Architect MyChart, University of Rochester Medical Center
Co-Chair, Quality Committee: Implementation and Operations, Golisano Children's Hospital

Subspecialty interests:
*Pediatric Hematopoietic Stem Cell Transplantation (HSCT)
*Infections of the Immunocompromised Host

Research